Economic evaluation of severe malaria in children under 14 years in Zambia.

Michael MtalimanjaKassim Said AbasseJames Lamon MtalimanjaXu Zheng YuanDu WenwenWei Xu

Published in: Cost effectiveness and resource allocation : C/E (2022)

The use of artesunate over quinine in the treatment of severe malaria in children under 14 years is a highly cost-effective strategy for the healthcare provider in Zambia.

Keyphrases

healthcare
young adults
plasmodium falciparum
early onset
drug induced
replacement therapy